Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04053673
Title RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors , FIH, MAD Study
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ribon Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Colorado Anschutz Medical Campus RECRUITING Aurora Colorado 80045 United States Details
SCRI-Denver/HealthOne RECRUITING Denver Colorado 80218 United States Details
Yale Cancer Center, Yale University RECRUITING New Haven Connecticut 06520 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists RECRUITING Orlando Florida 32827 United States Details
SCRI-Sarasota/Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Washington University RECRUITING Saint Louis Missouri 63110 United States Details
University of Pittsburgh Medical Center RECRUITING Pittsburgh Pennsylvania 15213 United States Details
SCRI-Nashville/Tennessee Oncology RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030-4009 United States Details
Hospital Quironsalud Barcelona - NEXT Oncology RECRUITING Barcelona 08023 Spain Details
Vall d'Hebron RECRUITING Barcelona 08035 Spain Details
Hospital Quironsalud Madrid - NEXT Oncology RECRUITING Madrid 28223 Spain Details
Hospital Clinic Universitario Biomedical Research institute INCLIVA RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field